Results 111 to 120 of about 11,103 (274)

The clinical question of mepolizumab in the long-term treatment of idiopathic chronic eosinophilic pneumonia; how long should we use mepolizumab?

open access: yesRespiratory Medicine Case Reports
The efficacy of mepolizumab as an alternative to glucocorticoids for treating idiopathic chronic eosinophilic pneumonia (ICEP) has been reported. However, various questions remain unanswered, such as the most appropriate dose and dosage interval of ...
Masamitsu Hamakawa   +7 more
doaj  

Effective treatment with mepolizumab in a patient with severe eosinophilic granulomatosis with polyangiitis complicated with small intestine perforation

open access: yesRespiratory Medicine Case Reports, 2023
Eosinophilic granulomatosis with polyangiitis (EGPA) is systemic vasculitis caused by eosinophilia affecting small to medium-sized blood vessels, which damages the organs.
Mari Sato   +17 more
doaj  

Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys [PDF]

open access: bronze, 2001
Timothy K. Hart   +12 more
openalex   +1 more source

Distinct Airway Inflammatory Pathways Associated with Asthma Exacerbations are Modulated by Mepolizumab Therapy in Children [PDF]

open access: yes, 2022
Rationale: Identification of specific airway inflammatory pathways can lead to effective personalized treatment with biologics in asthma and insights to mechanisms of action.
Altman, Matthew   +22 more
core   +1 more source

Anti–interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes☆ [PDF]

open access: bronze, 2004
Jennifer K. Garrett   +9 more
openalex   +1 more source

Mepolizumab and COPD in Real Life

open access: yesOpen Respiratory Archives, 2022
Fernando Revuelta-Salgado   +3 more
openaire   +4 more sources

Real-World Reductions in Oral Corticosteroid Use in the USA Following Mepolizumab Therapy for Severe Asthma

open access: yesJournal of Asthma and Allergy, 2020
Jared Silver,1 Michael Bogart,1 Elizabeth Packnett,2 Juan Wu,2 Donna McMorrow,2 Beth Hahn1 1US Medical Affairs, GSK, Research Triangle Park, NC, USA; 2Life Sciences, IBM Watson Health, Bethesda, MD, USACorrespondence: Beth Hahn Email beth.a.hahn@gsk ...
Silver J   +5 more
doaj  

Real-World Experience on the Use of Mepolizumab from the Severe Asthma Registry of the German Asthma Net (MepoGAN-Study)

open access: yesJournal of Asthma and Allergy, 2023
Stephanie Korn,1 Katrin Milger,2 Dirk Skowasch,3 Christian Schulz,4 Cordula Mohrlang,5 Martin Wernitz,5 Thomas Paulsson,6 Michael Hennig,5 Roland Buhl7 1IKF Pneumologie Mainz, Mainz and Thoraxklinik Heidelberg, Heidelberg, Germany; 2Department of ...
Korn S   +8 more
doaj  

Mepolizumab, a Humanized Monoclonal Antibody to IL-5, for Severe Eosinophilic Esophagitis in Adults: A Randomized, Placebo-Controlled Double-Blind Trial [PDF]

open access: bronze, 2007
Alex Straumann   +8 more
openalex   +1 more source

Mepolizumab for the Treatment of Eosinophilic Cystitis: Reply

open access: yesJournal of Investigational Allergology and Clinical Immunology
International ...
Trefond, Ludovic, Kahn, Je
openaire   +3 more sources

Home - About - Disclaimer - Privacy